XML 134 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Balance (in shares) at Mar. 31, 2021   46,566,481      
Balance at Mar. 31, 2021 $ 498,728 $ 47 $ 692,243 $ (193,168) $ (394)
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 224       224
Unrealized loss on short-term investments (40)       (40)
Exercise of stock options (in shares)   163,970      
Exercise of stock options 1,173   1,173    
Stock-based compensation expense 6,250   6,250    
Net loss (27,311)     (27,311)  
Balance (in shares) at Jun. 30, 2021   46,730,451      
Balance at Jun. 30, 2021 479,024 $ 47 699,666 (220,479) (210)
Balance (in shares) at Mar. 31, 2021   46,566,481      
Balance at Mar. 31, 2021 498,728 $ 47 692,243 (193,168) (394)
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 443        
Unrealized loss on short-term investments (40)        
Net loss (56,666)        
Balance (in shares) at Sep. 30, 2021   46,855,331      
Balance at Sep. 30, 2021 457,412 $ 47 707,190 (249,834) 9
Balance (in shares) at Jun. 30, 2021   46,730,451      
Balance at Jun. 30, 2021 479,024 $ 47 699,666 (220,479) (210)
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 219       219
Unrealized loss on short-term investments 0       0
Exercise of stock options (in shares)   124,880      
Exercise of stock options 1,211   1,211    
Stock-based compensation expense 6,313   6,313    
Net loss (29,355)     (29,355)  
Balance (in shares) at Sep. 30, 2021   46,855,331      
Balance at Sep. 30, 2021 457,412 $ 47 707,190 (249,834) 9
Balance (in shares) at Mar. 31, 2022   47,338,660      
Balance at Mar. 31, 2022 411,229 $ 47 723,359 (311,204) (973)
Increase (decrease) in Stockholders' Equity          
Shares issued during period (in shares)   1,686,438      
Issuance of common stock through ATM sales, net of offering costs 31,037 $ 2 31,035    
Foreign currency translation adjustment 1,737       1,737
Unrealized loss on short-term investments (244)       (244)
Exercise of stock options (in shares)   124,028      
Exercise of stock options 1,562   1,562    
Vesting of RSUs (in shares)   149,341      
Stock-based compensation expense 7,194   7,194    
Net loss (42,253)     (42,253)  
Balance (in shares) at Jun. 30, 2022   49,298,467      
Balance at Jun. 30, 2022 410,262 $ 49 763,150 (353,457) 520
Balance (in shares) at Mar. 31, 2022   47,338,660      
Balance at Mar. 31, 2022 411,229 $ 47 723,359 (311,204) (973)
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 4,067        
Unrealized loss on short-term investments $ (163)        
Exercise of stock options (in shares) 212,280        
Net loss $ (85,355)        
Balance (in shares) at Sep. 30, 2022   49,739,407      
Balance at Sep. 30, 2022 384,072 $ 50 777,650 (396,559) 2,931
Balance (in shares) at Jun. 30, 2022   49,298,467      
Balance at Jun. 30, 2022 $ 410,262 $ 49 763,150 (353,457) 520
Increase (decrease) in Stockholders' Equity          
Shares issued during period (in shares) 340,000 340,000      
Issuance of common stock through ATM sales, net of offering costs $ 6,401 $ 1 6,400    
Foreign currency translation adjustment 2,330       2,330
Unrealized loss on short-term investments 81       81
Exercise of stock options (in shares)   88,252      
Exercise of stock options 1,108   1,108    
Vesting of RSUs (in shares)   12,688      
Stock-based compensation expense 6,992   6,992    
Net loss (43,102)     (43,102)  
Balance (in shares) at Sep. 30, 2022   49,739,407      
Balance at Sep. 30, 2022 $ 384,072 $ 50 $ 777,650 $ (396,559) $ 2,931